The epidermal growth factor (EGF) family hormones amphiregulin (AR), transforming growth factor-␣ (TGF-␣), and heparin-binding EGF-like growth factor (HB-EGF) are thought to play significant roles in the genesis or progression of a number of human malignancies. However, the ability of these ligands to activate all four erbB family receptors has not been evaluated. Therefore, we have assessed the stimulation of erbB family receptor tyrosine phosphorylation by these hormones in a panel of mouse Ba/F3 cell lines expressing the four erbB family receptors, singly and in pairwise combinations. We also measured the stimulation of interleukin-3-independent survival or proliferation in this panel of Ba/F3 cell lines to compare the patterns of erbB family receptor coupling to physiologic responses induced by these peptides. EGF, TGF-␣, AR, and HB-EGF all stimulated qualitatively similar patterns of erbB family receptor tyrosine phosphorylation and coupling to physiologic responses. Therefore, EGF, TGF-␣, AR, and HB-EGF are functionally identical in this model system and behave differently from the EGF family hormones betacellulin and neuregulins.
The epidermal growth factor (EGF) family hormones amphiregulin (AR), transforming growth factor-␣ (TGF-␣), and heparin-binding EGF-like growth factor (HB-EGF) are thought to play significant roles in the genesis or progression of a number of human malignancies. However, the ability of these ligands to activate all four erbB family receptors has not been evaluated. Therefore, we have assessed the stimulation of erbB family receptor tyrosine phosphorylation by these hormones in a panel of mouse Ba/F3 cell lines expressing the four erbB family receptors, singly and in pairwise combinations. We also measured the stimulation of interleukin-3-independent survival or proliferation in this panel of Ba/F3 cell lines to compare the patterns of erbB family receptor coupling to physiologic responses induced by these peptides. EGF, TGF-␣, AR, and HB-EGF all stimulated qualitatively similar patterns of erbB family receptor tyrosine phosphorylation and coupling to physiologic responses. Therefore, EGF, TGF-␣, AR, and HB-EGF are functionally identical in this model system and behave differently from the EGF family hormones betacellulin and neuregulins.
Deregulation of the signaling network composed of the erbB family receptors and the epidermal growth factor (EGF) 1 family of peptide hormones plays an important role in a number of human metastatic diseases (reviewed in Ref. 1) . Several factors contribute to the complex regulation of this system. There are four distinct erbB family receptors, including the epidermal growth factor receptor (EGFR/erbB-1), neu (erbB-2/HER2), erbB-3 (HER3), and erbB-4 (HER4). Receptor signaling can be stimulated by at least six different EGF family hormones, including EGF, transforming growth factor-␣ (TGF-␣), amphiregulin (AR), betacellulin (BTC), heparin-binding EGF-like growth factor (HB-EGF), and the several differentially spliced variants of neuregulin (NRG), also known as neu differentiation factors, heregulins, glial growth factors, or acetylcholine receptor inducing activity (reviewed in Refs. [1] [2] [3] . A single erbB family receptor (e.g. EGFR) can bind several different EGF family hormones (EGF, TGF-␣, AR, HB-EGF) (reviewed in Refs. 1 and 2), and a single EGF family peptide (BTC) can activate more than one receptor (EGFR, erbB-4) (4). Furthermore, in cells expressing multiple erbB family receptors, EGF family peptides can induce the phosphorylation and signaling of erbB family receptors that, when expressed alone, are not phosphorylated, a process referred to as transmodulation (reviewed in Refs. 5 and 6). For example, EGF stimulates neu tyrosine phosphorylation when neu is coexpressed with the EGFR, but not when neu is expressed by itself (7) (8) (9) (10) . Indeed, with a single exception, every EGF family hormone tested thus far has the potential to regulate all four erbB family receptors through this mechanism (4, (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . The physiological relevance of transmodulation is supported in gene-targeting experiments in transgenic mice. Mice homozygous for disruptions in the NRG, neu, or erbB-4 genes all die in utero at day 10.5 and lack the trabecular extensions of the developing ventricular myocardium (20 -22) . The similarity of these cardiac defects suggests that NRG induction of both neu and erbB-4 signaling is required for cardiac morphogenesis. Since NRG regulates neu phosphorylation only through transmodulation (12) (13) (14) (15) (17) (18) (19) , erbB-4-dependent transmodulation of neu signaling by NRG plays a critical role in cardiac development.
Despite the relevance of erbB family receptor phosphorylation and transmodulation in regulating cellular proliferation and differentiation, the effects of TGF-␣, AR, and HB-EGF on erbB family receptor signaling have not been completely evaluated. All three of these molecules stimulate EGFR phosphorylation (11, 23, 24) , and both AR and TGF-␣ transmodulate neu (9, 11) . However, the abilities of these molecules to regulate erbB-3 and erbB-4, alone and in combination with other receptors, have not been comprehensively evaluated. Consequently, while all three of these molecules stimulate EGFR signaling, they may also differentially regulate signaling by the other three erbB family receptors. This might explain quantitative differences observed in the activities of AR, HB-EGF, and EGF (25, 26) . This possibility is underscored by our recent finding that BTC not only activates EGFR, but also activates erbB-4 (4). In this report we have evaluated AR, HB-EGF, and EGF activities by stimulating IL-3-dependent Ba/F3 mouse pro-B-lymphocyte cell lines that have been engineered to express, singly and in pairwise combinations, all four erbB family receptors (4, 17) .
EXPERIMENTAL PROCEDURES
Growth Factors-The production of recombinant HB-EGF has been described earlier (27) . Human recombinant EGF and TGF-␣ were supplied by Collaborative Biomedical Products. NRG was supplied as a chemically synthesized NRG-␤ 65-mer (17, 28) . Amphiregulin purification took advantage of the highly basic nature and high heparin affinity of AR. Due to the high isoelectric point (pI 10.1) of nonglycosylated AR, we compared AR refolding efficiency over a range of pH 7-11. Maximal activity was seen following refolding in 50 mM CAPS, pH 11.0.
AR was produced in bacteria under the control of the tightly regulated, thermoinducible bacteriophage PL promoter as described for betacellulin (4) with several modifications. The nucleotide sequence encoding an initiating methionine, 82 amino acids of the AR precursor (Val 107 -Thr 188 ), and a stop codon was inserted between the unique BglII and XbaI sites of pPLABTC-Tag (4). The resulting plasmid was grown and transformed into competent Escherichia coli N4830-1. AR expression was induced and bacteria were lysed and fractionated as described previously (4) . Recombinant AR was refolded in 50 mM CAPS at pH 11.0, followed by cation exchange and heparin affinity chromatography as described previously (4) . AR activity was monitored using an EGFR tyrosine phosphorylation assay and an AR-specific enzymelinked immunosorbent assay (29) .
The nonglycosylated bacterial AR migrated at 14 kDa, consistent with the N-glycanase-treated native AR. Furthermore, it was found to inhibit the binding of 125 I-EGF to NRHER5 membranes (which express EGFR) as well as to live cells (29) . A 50% inhibition of 125 I-EGF binding to NRHER5 membranes was seen at approximately 0.1 nM EGF (0.1 ng/well), 100 nM native AR or recombinant AR produced in COS cells (100 ng/well), and 150 nM bacterial AR (100 ng/well). Nonlabeled native and recombinant AR demonstrated an 85% maximal inhibition in these assays, confirming previous reports that AR has a relatively lower affinity than EGF to the EGFR.
Cell Lines and Cell Culture-The generation and characterization of the recombinant Ba/F3 cell lines used in this report have been described previously (17) . These 11 cell lines, which express the four erbB family receptors singly and in pairwise combinations, are: LXSN/1 (vector control); EGFR/3; neu/12C; erbB-3/3; erbB-4/7; EGFRϩneu/5D; EGFRϩerbB-3/4A; EGFRϩerbB-4/2A; neuϩerbB-3/7A; neuϩerbB-4/ 15A; and erbB-3ϩerbB-4/2B. Conditions for culturing these cell lines have been described earlier (17) .
Stimulation and Analysis of ErbB Family Receptor Tyrosine Phosphorylation-
The stimulation of erbB family receptor tyrosine phosphorylation in the recombinant Ba/F3 cell lines has been described previously (4, 17) . Cells were stimulated with ligand at the following final concentrations: NRG, 94 ng/ml; EGF, TGF-␣ or HB-EGF, 100 ng/ml; AR, 1280 ng/ml. Dose-response experiments established that these hormone concentrations induced saturated levels of receptor tyrosine phosphorylation (data not shown).
Analysis of erbB family receptor tyrosine phosphorylation by immunoprecipitation and anti-phosphotyrosine immunoblotting has been described previously (4, 17) . Immunoprecipitating anti-receptor antibodies were anti-EGFR mouse monoclonal antibody 528 (30), anti-Neu mouse monoclonal antibodies FSP16 (31), and TA-1 (Ab-5, Oncogene Science), anti-erbB-3 rabbit polyclonal antiserum SC-285 (Santa Cruz Biotechnology), and anti-erbB-4 rabbit polyclonal antiserum SC-283 (Santa Cruz Biotechnology). Specificity of anti-receptor antibodies has been verified by testing for cross-reactivity (data not shown) and previously we have established that hormone stimulation under these conditions does not appreciably modulate erbB family receptor protein levels (17) .
RESULTS

Stimulation of Receptor Phosphorylation in Cell Lines Expressing a Single ErbB Family
Receptor-In order to determine which receptors are activated individually by AR, TGF-␣, and HB-EGF, we first evaluated the activation of erbB family receptor phosphorylation in the cell lines that express single erbB family receptors. Each of these factors stimulated the phosphorylation of EGFR, but not of neu or erbB-4 (Figs. 1A and B) . In contrast, the positive control neuregulin-␤ (NRG) activated both neu and erbB-4 (Fig. 1A, lane 12; Fig. 1B, lane 12) . All four EGF family peptides tested failed to stimulate erbB-3 tyrosine phosphorylation (Fig. 1B, lanes 3-6) . This may be due to the minimal intrinsic kinase activity of erbB-3 (33, 34) and does not necessarily indicate that these hormones do not bind to erbB-3.
Stimulation of Receptor Phosphorylation in Cell Lines Expressing Two Different ErbB Family
Receptors-We then evaluated erbB family receptor phosphorylation in Ba/F3 cell lines that express pairwise combinations of receptors to assess the ability of these hormones to regulate erbB-2, erbB-3, and erbB-4 through transmodulation. AR, TGF-␣, and HB-EGF stimulated EGFR receptor phosphorylation in the EGFRϩneu, EGFRϩerbB-3, and EGFRϩerbB-4 cell lines ( Figs. 2A-C) . Furthermore, these hormones induced neu and erbB-4 tyrosine phosphorylation in the EGFRϩneu and EGFRϩerbB-4 cell lines, respectively (Figs. 2, A and C) . In contrast, TGF-␣ activated erbB-3 in the EGFRϩerbB-3 cell line, while AR and HB-EGF did not (Fig. 2B) .
HB-EGF, TGF-␣, and AR failed to activate erbB family re- ceptors in the NeuϩerbB-3, NeuϩerbB-4, and ErbB-3ϩerbB-4 cell lines, even though NRG induced receptor phosphorylation in all three cell lines (Figs. 3A-C) and HB-EGF, TGF-␣, and AR stimulated receptor phosphorylation in the EGFR cell line (Fig.  3A) . Therefore, HB-EGF, TGF-␣, and AR do not activate neu, erbB-3, or erbB-4 in the absence of EGFR expression and are presumably not ligands for these receptors.
Induction of IL-3-independent Survival or Proliferation in Ba/F3 Derivatives-While HB-EGF, TGF-␣, and AR induced similar patterns of erbB receptor phosphorylation, another potential source of signaling specificity is that different ligands may couple the same erbB family receptors to distinct sets of cellular signaling pathways. To assess this possibility we tested whether HB-EGF, TGF-␣, and AR induced different patterns of IL-3-independent survival or growth in the recombinant Ba/F3 cell lines. Our previous studies using these cell lines have established that activation of EGFR or neu, but not erbB-4, confers IL-3-independent survival, while activation of both EGFR and erbB-4 or EGFR and neu confers IL-3 independent proliferation (4, 17). As shown in Fig. 4 , the vector control cell line failed to respond to any of the factors, while all four ligands induced IL-3-independent survival in the EGFR and EGFRϩerbB-3 cell lines. (We judged that cultures exhibiting viable cell saturation densities of less than 10 ϫ 10 3 cells/ml were nonresponsive to hormone, while cultures with viable cell saturation densities of 20 -250 ϫ 10 3 cells/ml were exhibiting survival but not proliferation and cultures with viable cell saturation densities of greater than 500 ϫ 10 3 cells/ml were proliferating.) All four ligands stimulated IL-3-independent proliferation in the EGFRϩneu and EGFRϩerbB-4 cell lines. 2 Therefore, in every cell line tested, EGF, HB-EGF, TGF-␣, and AR induced growth responses that were quantitatively similar.
DISCUSSION
In this report we describe erbB family receptor tyrosine phosphorylation and coupling to cellular signaling pathways in response to the EGF family hormones AR, TGF-␣, and HB-EGF. This study is the first analysis of the interactions of these hormones with the complete suite of erbB family receptors. In these assays TGF-␣, AR, and HB-EGF were functionally nearly identical to each other and to EGF. These hormones stimulated only EGFR phosphorylation in the cell lines that express a single erbB family receptor, but TGF-␣ stimulated more EGFR phosphorylation than did HB-EGF or AR (Fig. 1) . TGF-␣, AR, and HB-EGF stimulated neu and erbB-4 phosphorylation in an EGFR-dependent manner (Fig. 2, A and C) . However, while TGF-␣ stimulated erbB-3 phosphorylation in the EGFRϩerbB-3 cell line, AR and HB-EGF failed to do so (Fig.  2B) .
The reduced activity of AR relative to the other hormones has been observed in other experiments as well. EGF and TGF-␣ stimulate anchorage independent growth of NRK cells in the presence of transforming growth factor beta, while AR does not, and AR does not compete as well as EGF itself for 125 I-EGF binding to A431 cells (25) . In our dose-response experiments, TGF-␣ stimulated markedly higher levels of EGFR phosphorylation than two independently prepared recombinant AR samples, not only in a recombinant Ba/F3 cell line, but also in 2 cells (an NIH/3T3-derived cell line) (35) engineered to overexpress EGFR. 3 Therefore, in our hands the reduced AR activity does not appear to be cell type-or preparation-specific, suggesting that AR may have reduced intrinsic activity compared to EGF and TGF-␣. Nonetheless, AR might not be properly folded when expressed in E. coli, or the amino-terminal glycosylation that is present when AR is expressed in mammalian cells and is absent when AR is expressed in E. coli may modulate AR activity.
While we observed quantitative differences in receptor phosphorylation stimulated by TGF-␣, AR, and HB-EGF, the physiologic responses to these factors were quantitatively quite similar. This was consistent with our earlier findings that the identity of receptors activated, rather than the number of activated receptors, determines the cellular response (4, 17) . These factors all stimulated the IL-3-independent survival of EGFR cells and the IL-3-independent proliferation of EGFRϩneu and EGFRϩerbB-4 cells. In the sole exception, AR stimulated a weaker response in the EGFRϩerbB-3 cell line compared to TGF-␣ or HB-EGF. This is concordant with the failure of AR and HB-EGF to stimulate erbB-3 phosphorylation in this cell line. These differences in TGF-␣, AR, and HB-EGF activity suggests that there are threshold levels of activity required for the detection of erbB-3 phosphorylation and the efficient induction of IL-3-independent survival. Because EGFR expression in the EGFRϩerbB-3 cell line is less than EGFR expression in the EGFR, EGFRϩneu, and EGFRϩerbB-4 cell lines (data not shown), the EGFRϩerbB-3 cell line is likely to be more sensitive to the reduced activity of AR and HB-EGF.
The specification of biological responses to the EGF family/ erbB receptor family signaling network is regulated at several distinct levels. We have previously demonstrated that the EGF (4, 17) . The recombinant Ba/F3 cell lines were made quiescent by growth to saturation density and were seeded at a density of 100 ϫ 10 3 cells/ml in medium lacking IL-3 (IL-3-Free), medium supplemented with IL-3, or in medium lacking IL-3 but supplemented with 10 ng/ml human recombinant EGF, 10 ng/ml HB-EGF, 10 ng/ml TGF-␣, or 128 ng/ml AR. Cells were stained with trypan blue and counted in a hemacytometer daily 2-4 days after seeding to determine viable cell saturation densities. Each combination of cell lines and factors was tested 6 -11 times and the arithmetic means of the viable cell saturation densities are indicated by the filled bars, while the standard errors of the means (32) are indicated by the error bars. Because cultures treated with IL-3-free medium exhibited viable saturation densities of less than 9 ϫ 10 3 cells/ml, these values, represented by the left-most bar for each cell line, may not be apparent.
family of hormones can be divided into three groups according to their ability to stimulate phosphorylation of different erbB family receptors. The data presented here permit us to assign TGF-␣, AR, and HB-EGF into these three functional groups (Table I) . Group I of EGF family hormones now consists of EGF, TGF-␣, AR, and HB-EGF. These peptides activate the EGFR in the absence of additional erbB family receptor expression and can stimulate the tyrosine phosphorylation of neu, erbB-4, and in some cases, erbB-3, in an EGFR-dependent manner. Group II of EGF family hormones consists of the NRGs. These peptides activate erbB-4 in the absence of additional erbB family receptor expression. However, the NRGs also bind to erbB-3, and activate it when coexpressed with any other erbB family receptor, and can stimulate neu or EGFR phosphorylation when these receptors are coexpressed with either erbB-3 or erbB-4. Group III of EGF family hormones consists solely of BTC. BTC activates EGFR or erbB-4 in the absence of additional erbB family receptor expression. Moreover, BTC stimulates neu tyrosine phosphorylation when neu is coexpressed with EGFR or erbB-4, and activates erbB-3 when erbB-3 is coexpressed with EGFR, but not when erbB-3 is coexpressed with erbB-4. Consequently, with one exception, hormonal activation of a single erbB family receptor can transmodulate any of the other three erbB family receptors. In different cells distinct EGF family hormones activate discrete sets of erbB family receptors, and biological responses to these hormones are specified in part by which erbB family receptors are expressed.
A corollary is that the activation of different erbB family receptors results in distinct biological responses (34, 36 -46) . We have observed such distinctions in our system. While EGFR activation results in the IL-3-independent survival of Ba/F3 cells and erbB-4 activation does not result in an IL-3-independent response, activation of both EGFR and erbB-4 results in IL-3-independent proliferation. Similarly, while activation of EGFR or neu alone results in IL-3-independent survival, activation of both EGFR and neu results in IL-3-independent proliferation (Table I) . EGFRϩerbB-4 cells stimulated with EGF, NRG, or BTC all undergo IL-3-independent proliferation, suggesting that the mechanism by which the receptors are activated does not appear to specify distinct biological responses. The stimulation of distinct biological responses by the four erbB family receptors apparently occurs through coupling of different sets of downstream signaling proteins to each receptor. Distinct sets of tyrosine phosphorylated proteins are coimmunoprecipitated with activated EGFR or activated erbB-4 (4). Experiments to identify these phosphoproteins and to determine their functional role in mediating erbB family receptor signaling are underway. 
a No increase in receptor tyrosine phosphorylation (Tyr phos) is indicated by "Ϫ," increased receptor tyrosine phosphorylation is indicated by "ϩ," and ambiguity due to high basal levels of receptor phosphorylation is indicated by "*."
b The absence of an IL-3-independent response is indicated by "N," stimulation of IL-3 independent survival is indicated by "S," and stimulation of IL-3 independent proliferation is indicated by "P." "NT" indicates not tested.
c The responses to NRGs are apparently due to interactions with the endogenous erbB-3 in Ba/F3 cells (17) . d Given the absence of receptor tyrosine phosphorylation, no IL-3 independent response is expected. e Results for EGF only. AR, TGF-␣, and HB-EGF were not tested, but a negative response to these ligands identical to that observed for EGF is anticipated because none of these hormones activated receptor phosphorylation in these cell lines.
